Product Information
BUPROPION HCL SR 200 MG TABLET is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.1617 per EA under NDC 70436006001. Its NADAC has been published 231 times since Dec 16, 2020.
Strength
200 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436006001
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
4/23/2025
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211347On Market Since
11/2/2020
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL SR 200 MG TABLET has been published 231 times since Dec 16, 2020, and over the history we have for it it has declined 32.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1617 per EA |
|---|---|
| All-time high | $0.2386 (Dec 16, 2020) |
| All-time low | $0.1063 (Nov 20, 2024) |
| Median price | $0.1489 |
| Average price | $0.1547 |
| Largest weekly change | +39.8% (May 19, 2021) |
| Weeks tracked | 231 |
| Tracking since | Dec 16, 2020 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPROPION HCL SR 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 200 MG TABLET, manufactured by Slate Run Pharmaceuticals LLC, is $0.1617 per EA (NDC 70436006001), effective May 14, 2025.
How has the price of BUPROPION HCL SR 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL SR 200 MG TABLET has declined 32.2%. It has been tracked across 231 weekly CMS publications since Dec 16, 2020.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 200 MG TABLET?
Since Dec 16, 2020, the NADAC for BUPROPION HCL SR 200 MG TABLET has ranged from a low of $0.1063 (Nov 20, 2024) to a high of $0.2386 (Dec 16, 2020), with a median of $0.1489 per EA.
Are there cheaper alternatives to BUPROPION HCL SR 200 MG TABLET?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BUPROPION HCL SR 200 MG TABLET, is $0.1109 per EA — about 31% below BUPROPION HCL SR 200 MG TABLET.
Who manufactures BUPROPION HCL SR 200 MG TABLET?
BUPROPION HCL SR 200 MG TABLET (NDC 70436006001) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification